A bombshell FTC report reveals how UnitedHealth marked up a leukemia drug by 5,232% - turning a $9,000 medication into a $478,000 bill. Through exclusive analysis and patient stories, this episode exposes how America's largest healthcare company generated $7.3 billion in excess revenue by inflating cancer drug prices. While families drain retirement accounts and sell homes to afford treatment, UnitedHealth announces record profits of $100.8 billion in their latest quarter. From operating room interruptions during cancer surgery to dying patients denied care, we examine how the company's pricing practices affect real lives. As one expert notes, "We're watching a battle between those trying to protect patients and those protecting profits."
